HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lada, P. Articles by Delgado, G. Search for Related Content PubMed PubMed Citation Articles by Lada, P. Articles by Delgado, G., Jr.

PAMELA LADA, PHARM.D., is Clinical Emergency Medicine Specialist, Department of Emergency Medicine, Boston Medical Center, Boston, MA. GEORGE DELGADO, JR., PHARM.D., is Coordinator, Emergency Pharmacy Services, and Clinical Emergency Medicine Specialist, Department of Emergency Medicine, Detroit Receiving Hospital and University Health Center, Detroit, MI.

Address correspondence to Dr. Lada at the Department of Pharmacy, Boston Medical Center, 88 East Newton Street, H2606, Boston, MA 02118 (pamela.lada{at}bmc.org).

Purpose. An analysis was conducted of pharmacist interventions and resuscitation experiences, including pharmacist participation in a hospital emergency department (ED), and the potential cost avoidance associated with the interventions made by the pharmacists. Methods. All pharmacists working in the ED prospectively documented the pharmacist interventions that were accepted by physicians and nursing staff and entered into a spreadsheet on a weekly basis, between September 1, 2003, and December 31, 2003. Intervention categories included the provision of drug information; recommendations for dosage adjustment, formulary interchange, initiation of medications, alternative drug therapy, discontinuation of drug therapy, changes in medication therapy due to allergy notification, drug therapy duplication prevention, or changes in the route of drug administration; questions from nursing staff; order clarifications; drug compatibility issues; patient information; toxicology; and drug interaction identification. Intervention data were analyzed and the likelihood of harm was scored; interventions were classified and analyzed by calculating average cost, probability of harm, and potential cost avoidance. Results. During the study, 2150 pharmacist interventions were documented. Pharmacists participated in the care of 1042 patients triaged to the resuscitation area of the ED. Cost avoidance during the study was determined to be $1,029,776. Conclusion. The most commonly documented interventions made by pharmacists involved in the care of patients visiting the ED included provision of drug information, dosage adjustment recommendations, responses to questions from nursing staff, formulary interchanges, and suggestions regarding initiation of drug therapy. The potential cost avoidance attributable to the pharmacist interventions during the study period was over $1 million. Index terms: Dosage; Drug information; Economics; Hospitals; Interventions; Pharmaceutical services; Pharmacists, hospital; Pharmacy, institutional, hospital; Substitution

 

This article has been cited by other articles:

				T. De Rijdt, L. Willems, and S. Simoens Economic effects of clinical pharmacy interventions: A literature review Am. J. Health Syst. Pharm., June 15, 2008; 65(12): 1161 - 1172. [Abstract] [Full Text] [PDF]

				E. S. Wymore, T. J. Casanova, R. L. Broekemeier, and J. K. Martin Jr. Clinical pharmacist's daily role in the emergency department of a community hospital Am. J. Health Syst. Pharm., March 1, 2008; 65(5): 395 - 399. [Full Text] [PDF]

				J. N. Brown, C. L. Barnes, B. Beasley, R. Cisneros, M. Pound, and C. Herring Effect of pharmacists on medication errors in an emergency department Am. J. Health Syst. Pharm., February 15, 2008; 65(4): 330 - 333. [Abstract] [Full Text] [PDF]